Provided by Tiger Fintech (Singapore) Pte. Ltd.

RENOVARO BIOSCIENCES INC

0.3151
-0.0446-12.40%
Volume:433.25K
Turnover:143.05K
Market Cap:50.44M
PE:-0.38
High:0.3597
Open:0.3597
Low:0.3150
Close:0.3597
Loading ...
Apr 30, 2024

Major Issues Report

Form 8-K - Current report
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 24, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Apr 08, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 13, 2024

Major Issues Report

Form 8-K - Current report
Mar 12, 2024

Correspondence

Form CORRESP - Correspondence
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Feb 22, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Jan 26, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]